LifeMD, Inc. (LFMD) Tops Q4 EPS by 29c

LifeMD, Inc. (NASDAQ: LFMD) reported Q4 EPS of $0.15, $0.29 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $44.86 million versus the consensus estimate of $40.49 million.

For earnings history and earnings-related data on LifeMD, Inc. (LFMD) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Computacenter Plc. (CCC:LN) PT Raised to GBP60 at JPMorgan
• Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)